US

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Republic of Korea *

welcome-institute-lig4-expert-interview1920x640

Whitepaper

Generating a clonal HAP1LIG4(-) Cas9(+) cell line – an expert interview

By incorporating a stably expressed Cas9 nuclease into Revvity’s HAP1 LIG4(-) cell line, the Sanger Institute has generated a new cell line that is highly amenable to efficient CRISPR/Cas9-mediated genomic modifications.

Read our interview with Dr. Sebastian Gerety, Principal Staff Scientist in the Human Genetics Program at the Sanger Institute, in which he discusses:

Why they developed this new HAP1 cell line
How leveraging the HAP1 LIG4(-) cell line developed with Revvity will help to accelerate the Sanger Institute’s research goals
How he envisions this new cell line impacting scientific discovery

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

Have a sales representative contact me

First Name

Last Name

Country

Email Address

Company

Zip / Postal Code

Business Phone

Role

Products and Services of Interest

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

Download Resource

Generating a clonal HAP1LIG4(-) Cas9(+) cell line – an expert interview

Download Whitepaper